CLINICAL_TRIALS
trial_result
· 2019-06-10
Clinical Trial Update: Pomalidomide for Myelofibrosis Patients [Phase 2]
Summary
Phase 2 clinical trial evaluating pomalidomide in myelofibrosis patients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Polycythemia Vera, Thrombocythemia | Phase 2 | Status: COMPLETED | Results posted: 2019-06-10